ADHD treatment in adults usually consists of medication and/or psychotherapy, whereby the success of medication is usually higher than the success of psychotherapy. However, ADHD treatment with medication often leads to undesired side effects and must also be closely monitored. The development of further, more effective ADHD therapy approaches with few side effects therefore appears to be urgently indicated.
The goal of the BMBF-funded project ATTENTION (= Mobile System for ADHD Therapy by Transcranial Electrical Neurostimulation) is the development of a novel medical-technical system for the targeted neuromodulation of attention-associated cortical networks by electrostimulation. Specifically, a demonstrator is to be developed with which attention-relevant EEG signals can be extracted and modulated by tACS. This demonstrator will then be tested in several studies, initially in healthy volunteers and later also in ADHD patients.
The project group hearing, speech and audio technology of the Fraunhofer Institute for Digital Media Technology (IDMT) is employed in the following areas is dealing with technologies...Read more
neuroConn GmbH is a worldwide active developer and producer of diagnostic and Therapy devices in The company is certified according to ISO 13485. It turn high quality multifunctional...Read more
Ascora GmbH is an SME based in northern Germany. Ascora is developing and selling software as an Independent Software Vendor with products that are used around the world...Read more
Applied Biosignals GmbH has his roots in the Institute for Developmental Neurology of the University Groningen (Prof. Prechtl). One of the founders is ...Read more
The core competencies of the General Psychology working group of the university Oldenburg by Prof. Dr. Herrmann (Faculty VI, part of the European Medical School), count...Read more
Bonn University Hospital is one of the maximum care providers in NRW. Among the Core competencies of the Clinic for...Read More